Top ▲

Nuclear export proteins

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

GtoImmuPdb view: OFF   

Overview

« Hide

Cancer cells are able inactivate the function of tumour suppressor proteins (TSPs) by overexpressing the nuclear export protein, XPO1, which results in TSP mislocalisation to the cytopasm. Pharmacological inhibition of XPO1 in cancer cells promotes nuclear retention of TSP cargo proteins such as p53, Foxo, and BRCA1, and this activity restores TSP function and leads to cycle arrest and enhanced cancer cell apoptosis. This approach is being expoited as a novel anti-cancer mechanism [1-2].

Targets

exportin 1 Show summary » More detailed page

References

Show »

How to cite this family page

Database page citation:

Nuclear export proteins. Accessed on 13/12/2018. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=1001.

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, Striessnig J, Davies JA; CGTP Collaborators. (2017) The Concise Guide to PHARMACOLOGY 2017/18: Overview. Br J Pharmacol. 174 Suppl 1: S1-S16.